RxSight Inc (RXST)
60.72
-1.38
(-2.22%)
USD |
NASDAQ |
May 08, 16:00
58.36
-2.36
(-3.89%)
After-Hours: 17:52
RxSight Enterprise Value: 2.185B for May 7, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 2.185B |
| May 06, 2024 | 2.212B |
| May 03, 2024 | 2.169B |
| May 02, 2024 | 2.093B |
| May 01, 2024 | 1.984B |
| April 30, 2024 | 1.814B |
| April 29, 2024 | 1.855B |
| April 26, 2024 | 1.836B |
| April 25, 2024 | 1.804B |
| April 24, 2024 | 1.839B |
| April 23, 2024 | 1.916B |
| April 22, 2024 | 1.820B |
| April 19, 2024 | 1.792B |
| April 18, 2024 | 1.798B |
| April 17, 2024 | 1.839B |
| April 16, 2024 | 1.894B |
| April 15, 2024 | 1.855B |
| April 12, 2024 | 1.922B |
| April 11, 2024 | 1.931B |
| April 10, 2024 | 1.834B |
| April 09, 2024 | 1.923B |
| April 08, 2024 | 1.969B |
| April 05, 2024 | 1.924B |
| April 04, 2024 | 1.807B |
| April 03, 2024 | 1.779B |
| Date | Value |
|---|---|
| April 02, 2024 | 1.748B |
| April 01, 2024 | 1.750B |
| March 31, 2024 | 1.791B |
| March 28, 2024 | 1.781B |
| March 27, 2024 | 1.747B |
| March 26, 2024 | 1.690B |
| March 25, 2024 | 1.685B |
| March 22, 2024 | 1.669B |
| March 21, 2024 | 1.764B |
| March 20, 2024 | 1.674B |
| March 19, 2024 | 1.685B |
| March 18, 2024 | 1.602B |
| March 15, 2024 | 1.618B |
| March 14, 2024 | 1.582B |
| March 13, 2024 | 1.676B |
| March 12, 2024 | 1.747B |
| March 11, 2024 | 1.736B |
| March 08, 2024 | 1.817B |
| March 07, 2024 | 1.865B |
| March 06, 2024 | 1.860B |
| March 05, 2024 | 1.888B |
| March 04, 2024 | 1.947B |
| March 01, 2024 | 1.933B |
| February 29, 2024 | 1.891B |
| February 28, 2024 | 1.959B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
125.91M
Minimum
Jan 07 2022
2.212B
Maximum
May 06 2024
613.24M
Average
332.85M
Median
Sep 15 2021
Enterprise Value Benchmarks
| Abbott Laboratories | 192.86B |
| Alphatec Holdings Inc | 2.168B |
| AtriCure Inc | 1.015B |
| Intuitive Surgical Inc | 133.14B |
| iRhythm Technologies Inc | 3.379B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.10M |
| Revenue (Quarterly) | 29.51M |
| Total Expenses (Quarterly) | 40.18M |
| EPS Diluted (Quarterly) | -0.25 |
| Gross Profit Margin (Quarterly) | 70.09% |
| Profit Margin (Quarterly) | -30.83% |
| Earnings Yield | -2.06% |
| Normalized Earnings Yield | -1.994 |